Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

PHASE2CompletedINTERVENTIONAL
Enrollment

443

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Onychomycosis
Interventions
DRUG

NB-002

DRUG

Vehicle control

Trial Locations (24)

23507

Virginia Clinical Research, Inc., Norfolk

33144

International Dermatology Research, Miami

47713

Welborne Clinic, Evansville

48038

Michigan Center for Research Corp., Clinton Township

55432

Minnesota Clinical Study Center, Fridley

77802

J & S Studies, Inc., Bryan

78229

Endeavor Clinical Trials, PA, San Antonio

78759

DermResearch Inc., Austin

83704

Northwest Clinical Trial, Boise

84124

Dermatology Research Center, Inc., Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

97210

Oregon Dermatology and Research Center, Portland

97223

Oregon Medical Research Center, PC, Portland

A1B 4S8

Newlab Clinical Research, Inc., St. John's

B3H 1A4

Eastern Canada Cutaneous Research Associates, LTD, Halifax

L4M 6L2

Ultranova Skincare, Barrie

N6A 3H7

The Guenther Dermatology Research Centre, London

L3P 1A8

Lynderm Research, Inc., Markham

L4Y 1A6

Dermatology Clinic, Mississauga

L6K1E1

EntraLogix Clinical Group, Inc., Oakville

N2J 1C4

K. Papp Clinical Research, Waterloo

H2K 4L5

Innovaderm Research, Inc., Montreal

H3H 1U4

International Dermatology Research, Inc., Montreal

G1V 4X7

Centre de Reeberche Dermatologique du Quebec Metropolitain (CRDQ), Québec

Sponsors
All Listed Sponsors
lead

NanoBio Corporation

INDUSTRY